Sanis Health

What Sanis Health does

Sanis Health Inc. is a Canadian-owned generic pharmaceutical manufacturer founded in 2009 and headquartered at 1 Presidents Choice Circle in Brampton, Ontario. The company manufactures and distributes a portfolio of 17 generic medicines spanning therapeutic areas including cardiovascular conditions (Amlodipine, Atenolol, Atorvastatin, ASA EC, Amiodarone), antibiotics (Amoxicillin capsules and suspension, Amoxicillin/Clavulanate, Azithromycin), anticoagulation (Apixaban), mental health (Aripiprazole, Atomoxetine), migraine (Almotriptan), oncology (Anastrozole), bone health (Alendronate), urinary conditions (Alfuzosin), and malaria prevention (Atovaquone Proguanil). These are established generic formulations of off-patent molecules, with the company emphasizing patient safety innovations such as simplified packaging as differentiators.

Sanis operates as a B2B pharmaceutical manufacturer selling through Canadian pharmacy and healthcare distribution channels. The company maintains medical information services via a dedicated telephone line (1-866-236-4076), fax, and email ([email protected]), along with a product inquiries channel ([email protected]) and a PharmaPOD-powered inquiry portal handling drug reactions, product complaints, medical information requests, and compassionate care cases. Distribution is domestic-only, with availability tracked via Drug Shortages Canada.

The company functions as a subsidiary of Loblaw Companies Limited, Canada's largest retailer, which operates Shoppers Drug Mart and other pharmacy assets. This parent-subsidiary relationship provides Sanis with structural distribution leverage and shared corporate services (the privacy program is administered by Loblaw's Chief Privacy Officer). The company holds registered trademarks for "SANIS" and "SANIS ADVANCED SOLUTIONS IN MEDICINE." Pricing is not publicly disclosed, and the firm operates with a small headcount of 11-50 employees, suggesting a lean commercial operation with likely outsourced manufacturing. No revenue figures, funding rounds, M&A activity, or leadership changes are publicly disclosed.

Name

Sanis Health

Legal name

Sanis Health Inc.

Website

https://sanis.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Sanis Health is a Canadian-owned generic pharmaceutical manufacturer, founded in 2009 and headquartered in Brampton, Ontario, producing 17 generic medicines distributed through Canadian pharmacies. It operates as a subsidiary of Loblaw Companies Limited, leveraging the parent's pharmacy distribution network.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Generic pharmaceuticals
• Pharmaceutical manufacturing
• Canadian healthcare
• Patient safety packaging
• Generic medicines

Headquarters

HQ city

Brampton

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Generic Pharmaceutical Sales: Revenue generated from manufacturing and selling generic medicines to the Canadian market through pharmacy and healthcare distribution channels.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Sanis Health manufactures and supplies a portfolio of 17 generic pharmaceutical products for the Canadian market, spanning therapeutic areas including cardiovascular, antibiotics, mental health, ADHD, migraine, anticoagulation, oncology, malaria prevention, and bone-related conditions. The company focuses on innovative, simplified packaging and patient safety features while delivering generic medicines through Canadian pharmacy and healthcare distribution channels.

Product overview

Sanis Health is a Canadian-owned pharmaceutical manufacturer founded in 2009 that offers a portfolio of generic medicines. The company provides 17 generic pharmaceutical products including Alendronate, Alfuzosin, Almotriptan, Amiodarone, Amlodipine, Amoxicillin (Capsules and Suspension), Amoxicillin/Clav, Anastrozole, Apixaban, Aripiprazole, ASA EC, Atenolol, Atomoxetine, Atorvastatin, Atovaquone Proguanil, and Azithromycin. These products span therapeutic areas including cardiovascular conditions, antibiotics, mental health, and other treatments. The company focuses on bringing innovation and advanced solutions to ensure Canadians have access to high-quality medication.

Differentiator

Problem solved

Functional benefit

Products and services

• Alendronate Generic formulation of Alendronate Sodium for bone-related conditions.
• Alfuzosin Generic formulation of Alfuzosin Hydrochloride for urinary conditions.
• Almotriptan Generic formulation of Almotriptan Malate for migraine treatment.
• Amiodarone Generic formulation of Amiodarone Hydrochloride for cardiac arrhythmias.
• Amlodipine Generic formulation of Amlodipine Besylate for cardiovascular conditions.
• Amoxicillin (Capsules) Generic formulation of Amoxicillin Trihydrate in capsule form for bacterial infections.
• Amoxicillin (Suspension) Generic formulation of Amoxicillin Trihydrate in oral suspension form for bacterial infections.
• Amoxicillin/Clav Generic formulation of Amoxicillin with Clavulanate Potassium for bacterial infections.
• Anastrozole Generic formulation of Anastrozole for breast cancer treatment.
• Apixaban Generic formulation of Apixaban for anticoagulation.
• Aripiprazole Generic formulation of Aripiprazole for mental health conditions.
• ASA EC Generic formulation of Acetylsalicylic Acid (Enteric Coated) for cardiovascular conditions.
• Atenolol Generic formulation of Atenolol for cardiovascular conditions.
• Atomoxetine Generic formulation of Atomoxetine Hydrochloride for ADHD treatment.
• Atorvastatin Generic formulation of Atorvastatin Calcium for cholesterol management.
• Atovaquone Proguanil Generic formulation of Atovaquone with Proguanil Hydrochloride for malaria prevention.
• Azithromycin Generic formulation of Azithromycin Dihydrate for bacterial infections.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Direct peers

• Apotex Inc. Apotex is the largest Canadian-owned generic pharmaceutical manufacturer, producing a broad range of generic oral solids, injectables, and APIs. Directly comparable to Sanis in therapeutic breadth, Canadian market focus, and B2B pharmacy distribution model.
• Pharmascience Inc. Pharmascience is a Canadian-owned generic pharmaceutical manufacturer headquartered in Montreal, producing generic prescription and OTC products. Closely comparable in scale, ownership profile, and Canadian market focus.
• Jamp Pharma Group: Jamp Pharma is a Canadian-owned generic pharmaceutical manufacturer with a broad portfolio of prescription generics, OTCs, and consumer health products. Comparable in scale, Canadian market focus, and therapeutic breadth.
• Mint Pharmaceuticals Inc. Mint Pharmaceuticals is a Canadian generic manufacturer offering prescription generics and specialty products. Comparable as a similarly-sized Canadian generic manufacturer competing in the same pharmacy channels.
• Marcan Pharmaceuticals Inc. Marcan Pharmaceuticals is a Canadian generic pharmaceutical manufacturer producing generic prescription medicines for the Canadian market. Comparable in size, geographic focus, and B2B distribution model.
• AA Pharma Inc. AA Pharma is a Canadian generic pharmaceutical company that develops, manufactures, and markets generic prescription drugs. Comparable in therapeutic focus, Canadian market, and B2B pharmacy model.

Broad incumbents

• Teva Canada: Teva is one of the world's largest generic pharmaceutical manufacturers with a significant Canadian subsidiary offering a wide portfolio of generics and specialty medicines. Comparable as a direct competitor in the Canadian generic market but materially larger and globally diversified.
• Sandoz Canada: Sandoz is the global generics and biosimilars division of Novartis and operates a Canadian subsidiary supplying generic prescription medicines. Comparable product category and Canadian distribution footprint, but operates as part of a much larger global generics platform.

Emerging players

• SteriMax Inc. SteriMax is a Canadian specialty pharmaceutical company focused on sterile injectables and specialty generics. Comparable as a Canadian-based manufacturer competing in adjacent generic categories with overlap in the Canadian institutional market.
• Ascendia Pharmaceuticals: Ascendia Pharmaceuticals is a Canadian specialty pharmaceutical company providing generic and specialty drug development and manufacturing. Comparable as a smaller Canadian manufacturer with partial product overlap and similar B2B channel orientation.

Market position

Strengths4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/sanis-health-inc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sanis Health